Journals / Türk Toraks Dergisi / 2010 / Cilt: 11 - Sayı: 2

Acebutolol'e bağlı masif plevral kalınlaşma

Acebutolol-induced massive pleural thickening

Pages
90–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our case, Naranjo Adverse Drug Reaction probability scale score indicated that massive pleural thickening was a possible adverse reaction associated with long term use of acebutolol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Many patients take beta-blockers to control hypertension or angina, and such medication is often continued for years.
📊
Key Findings & Data:Drug-induced pulmonary diseases due to beta-blockers have been published previously as pulmonary parenchymal infiltration and pleurisy, but bilateral multifocal and extensive pleural thickening alone has not been mentioned previously.
💡
Conclusion & Impact:In our case, Naranjo Adverse Drug Reaction probability scale score indicated that massive pleural thickening was a possible adverse reaction associated with long term use of acebutolol.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Many patients take beta-blockers to control hypertension or angina, and such medication is often continued for years. Drug-induced pulmonary diseases due to beta-blockers have been published previously as pulmonary parenchymal infiltration and pleurisy, but bilateral multifocal and extensive pleural thickening alone has not been mentioned previously. In our case, Naranjo Adverse Drug Reaction probability scale score indicated that massive pleural thickening was a possible adverse reaction associated with long term use of acebutolol.

Özet

Birçok hasta hipertansiyon veya anjina için beta-bloker alır ve bu ilaçları yıllarca kullanır. Daha önceki yıllarda beta-blokerlere bağlı pulmoner hastalık olarak pulmoner parankimal infiltrasyon ve plörezi yayınlaşmışken bilateral multifokal yaygın plevral kalınlaşma bildirilmemiştir. Bizim vakamızda Naranjo ilaç yan etkisi olasılık skala skoruna göre yaygın plevral kalınlaşma uzun dönem acebutolol kullanımının olası bir yan etkisidir.

🔖

Cite This Article

KIYAN, E., TÜLEK, B., KILIÇASLAN, Z., YILMAZBAYHAN, D. (2010). Acebutolol'e bağlı masif plevral kalınlaşma. Türk Toraks Dergisi, Cilt: 11 - Sayı: 2, 90–92. https://ajindex.com/articles/329008

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Camus P. Respiratory diseases induced by drugs. Eur Respir J 1997;10:260-4
  2. Morelock SY, Sahn SA. Drugs and Pleura. Chest 1999; 116:212-21
  3. Camus P, Lombard JN, Perrichon M, et al. Bronchiolitis obliterans organizing pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44:711-5
  4. Record NB Jr. Acebutolol-induced pleuropulmonary lupus syndrome. Ann Intern Med 1981;95:326-7
  5. Akoun GM, Cadranel JL, Milleron BJ, et al. Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991;99:98-104
  6. Leggett RJ. Pleurisy and pulmonary granulomas after treatment with acebutolol (Letter). Brit Med J 1982;285:1425
  7. Wood GM, Bolton RP, Muers MF, et al. Pleurisy and pulmonary granulomas after treatment with acebutolol. Brit Med J 1982;285:936
  8. Dyer NH, Varley CC. Practolol-induced pleurisy and constrictive pericarditis (Letter). Br Med J 1975;2:443
  9. MacKay AD, Axford AT. Pleural effusions after practolol (Letter). Lancet 1976;1:89
  10. Hall DR, Morrison JB, Edwards FR. Pleural fibrosis after practolol therapy. Thorax 1978;33:822-4
  11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.